Water-Soluble Contrast Swallow
The water soluble contrast swallow is a fluoroscopic study of the pharynx, oesophagus, stomach and, in the postoperative setting, the anastomosis or conduit, after the patient drinks a water soluble iodinated contrast agent in place of barium.
A low osmolar or iso osmolar non-ionic agent (for example iohexol, iopamidol or iodixanol, 150 to 300 mg iodine in each mL, diluted if there is a risk of aspiration) is swallowed in volumes of 20 to 100 mL. Images are taken in the erect, oblique and prone positions in real time.
It is used when barium is unsuitable: suspected perforation, anastomotic leak, fistula, recent surgery, risk of aspiration, or before endoscopy or surgery in a patient with obstruction. The effective dose is about 1 to 3 mSv, depending on the length of fluoroscopy.
Barium in the mediastinum or pleura causes severe inflammation and fibrosis, and barium in the airway can cause pneumonitis, so water soluble contrast is the first agent for any suspected leak.
Oesophageal perforation has a high mortality (10 to 25% overall, up to 40% or more if treatment is delayed beyond 24 hours). Anastomotic leak after oesophagectomy occurs in 5 to 15%, after gastrectomy in 2 to 5%, and after gastric bypass or sleeve gastrectomy in 1 to 5%. A fast, accurate study affects survival.
Water soluble contrast is less dense than barium, so it is less sensitive for small leaks; CT with oral contrast adds sensitivity and shows collections.
Indications. Suspected oesophageal perforation (after vomiting, instrumentation, foreign body, trauma, caustic ingestion or surgery). Suspected anastomotic leak after oesophagectomy, gastrectomy, bariatric surgery, or fundoplication. Suspected fistula (tracheo oesophageal, bronchopleural). Assessment before starting oral feeding after oesophageal or gastric surgery.
Suspected high grade obstruction (food bolus impaction, tumour) before endoscopy. Dysphagia with a risk of aspiration or an incompetent swallow, when a first look at the swallow is needed. Foreign body ingestion with suspected perforation. Post-operative gastric band or sleeve complications.
Congenital oesophageal anomalies in the neonate (a small volume of non-ionic contrast through a tube for the H-type fistula, atresia). Small bowel obstruction in the post-operative or adhesive setting, as a diagnostic and therapeutic test (a water soluble follow through). Not for the routine investigation of reflux or motility, for which barium and manometry are better.
Contraindications and precautions. Aspiration risk: hypertonic ionic agents (such as diatrizoate, high osmolality) draw fluid into the lungs and cause severe pulmonary oedema, so only low osmolar non-ionic agents are used when aspiration is possible, and the volume is small.
Allergy to iodinated contrast (oral absorption is small, but a reaction is possible, and absorption increases through a leak or an inflamed mucosa). Hyperthyroidism or thyroid disease (iodine load). Renal impairment (small absorbed dose, but increases with leakage). Neonates and infants: hyperosmolar agents cause fluid shifts, so only non-ionic, low osmolar contrast is given.
Pregnancy: avoid unless essential. A patient who is hypotensive, septic or unstable needs resuscitation before the study, and a CT may be the preferred test.
Preparation and technique. Nil by mouth for 4 to 6 hours before an elective study (no wait in an emergency). A small amount of contrast (10 to 20 mL) is swallowed first in the oblique position to show the pharynx and cervical oesophagus, followed by larger volumes with the patient turned from left to right to show the whole oesophagus, stomach and anastomosis.
A feeding tube or a nasogastric tube is used to instil contrast in patients who cannot swallow. If the first study is negative and the suspicion remains high, a second study with barium (if the risk of aspiration is low) or a CT scan with oral contrast is performed.













